Showing 3 Abstracts.
08 : 30 AM
DR10624, a First-In-Class, FGF21 Receptor/Glucagon Receptor/GLP-1 Receptor Triple Agonist, Rapidly and Significantly Reduced Triglycerides, Atherogenic Lipids, and Liver Fat in Patients With Severe Hypertriglyceridemia: Primary Results From a Randomized Phase 2 Trial.
Li Jianping, Zhou Zijian, Lv Lingchun, Gan Yulong, Wang Ying, Zhu Chaonan, Xu June, Huang Yanshan, Fang Yongliang, Zhang Long, Fan Yanting, Zhang Shu, Wang Liyun, Qu Yanling, Yin Guotian, Jiang Hongwei
Final Pr. ID: -
Authors: Li Jianping , Zhou Zijian , Lv Lingchun , Gan Yulong , Wang Ying , Zhu Chaonan , Xu June , Huang Yanshan , Fang Yongliang , Zhang Long , Fan Yanting , Zhang Shu , Wang Liyun , Qu Yanling , Yin Guotian , Jiang Hongwei
Keywords: Triglycerides, Dyslipidemia, HDL elevating therapies, Cholesterol-lowering drugs, Adiponectin
10 : 00 AM
Lipoprotein Apheresis improves HDL Proteomics and reduces the risk of Aortic Stenosis in patients with elevated Lipoprotein(a) levels and Familial Hypercholesterolemia
Moriarty Patrick, Safarova Maya
Final Pr. ID: MDP4
Authors: Moriarty Patrick , Safarova Maya
Keywords: Aortic valve stenosis, HDL elevating therapies, Atherosclerosis, Lipoproteins, Proteome
02 : 30 PM
Obicetrapib in Patients with Dyslipidemia with or without Atherosclerotic Cardiovascular Disease Risk: A Meta-Analysis of Randomized Controlled Trials
Emara Ahmed, Shubietah Abdalhakim, Elgendy Mohamed, Rifai Mohamed, Gadelmawla Ahmed Farid, Diaa Ahmed, Emara Mohamed, A. Elshewikh Mohamed, Megaly Michael
Final Pr. ID: Sa3072
Authors: Emara Ahmed , Shubietah Abdalhakim , Elgendy Mohamed , Rifai Mohamed , Gadelmawla Ahmed Farid , Diaa Ahmed , Emara Mohamed , A. Elshewikh Mohamed , Megaly Michael
Keywords: HDL elevating therapies, Hyperlipidemia